CME credits: 0.25 
Valid until: 30-07-2024 
Claim your CME credit at <a href="https://reachmd.com/programs/cme/asco-2023-updates-on-targeting-her3-in-breast-and-lung-cancers/15055/">https://reachmd.com/programs/cme/asco-2023-updates-on-targeting-her3-in-breast-and-lung-cancers/15055/</a> 


 
 <a>Feeling overwhelmed by the latest NSCLC and breast cancer advances, including novel HER3-targeted agents? Here’s how you can stay up to date.</a>=

CME credits: 0.25 Valid until: 30-07-2024 Claim your CME credit at https://reachmd.com/programs/cme/asco-2023-updates-on-targeting-her3-in-breast-and-lung-cancers/15055/ Feeling overwhelmed by the latest NSCLC and breast cancer advances, including novel HER3-targeted agents? Here’s how you can stay up to date.=

CME credits: 0.25 
Valid until: 30-07-2024 
Claim your CME credit at <a href="https://reachmd.com/programs/cme/asco-2023-updates-on-targeting-her3-in-breast-and-lung-cancers/15055/" rel="noopener noreferrer">https://reachmd.com/programs/cme/asco-2023-updates-on-targeting-her3-in-breast-and-lung-cancers/15055/</a> 


 
 <a rel="noopener noreferrer">Feeling overwhelmed by the latest NSCLC and breast cancer advances, including novel HER3-targeted agents? Here’s how you can stay up to date.</a>=

ASCO 2023 Updates on Targeting HER3 in Breast and Lung Cancers

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Share ASCO 2023 Updates on Targeting HER3 in Breast and Lung Cancers

Sign up to save your podcasts

ASCO 2023 Updates on Targeting HER3 in Breast and Lung Cancers

ASCO 2023 Updates on Targeting HER3 in Breast and Lung Cancers